Showing outcomes and proving value brings success.
Today's pharmacoeconomics have shown how critical it is to find value in formulary drug products. For Regence BlueShield, Seattle, this means outcomes; making sure a drug truly works better than well-established alternatives, not just placebos. In 1998, Regence adopted formulary submission guidelines that have proven a solid success, and have been adopted by the Academy of Managed Care Pharmacy, Alexandria, Virginia, for evaluation nationwide.
Fullerton
D S
DS
Pharmacy Services, Regence BlueShield, Seattle, USA. pfullerton@regence.com
Atherly
D
D
Sullivan
S D
SD
D054598:Blue Cross Blue Shield Insurance Plans / Q000191:economics / Q000458:organization & administration*; D002986:Clinical Trials as Topic; D003659:Decision Making, Organizational; D004282:Documentation / Q000592:standards*; D004345:Drug Industry; D019317:Evidence-Based Medicine; D005569:Formularies as Topic; D017408:Guidelines as Topic; D006801:Humans; D008329:Managed Care Programs / Q000458:organization & administration*; D019982:Organizational Case Studies; D010606:Pharmacy and Therapeutics Committee; D010919:Placebos; D016896:Treatment Outcome; D014481:United States; D014861:Washington
D010919:Placebos